$2.64 Billion is the total value of Aequim Alternative Investments LP's 105 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | ALNYLAM PHARMACEUTICALS INCnote 1.000% 9/1 | $27,825,000 | – | 30,000,000 | +100.0% | 1.06% | – | |
FLR | New | FLUOR CORP NEW | $12,157,499 | – | 331,267 | +100.0% | 0.46% | – |
New | ON SEMICONDUCTOR CORPnote 5/0 | $10,830,000 | – | 6,000,000 | +100.0% | 0.41% | – | |
SGEN | New | SEAGEN INC | $10,607,500 | – | 50,000 | +100.0% | 0.40% | – |
New | LUMENTUM HLDGS INCnote 0.500% 6/1 | $7,313,000 | – | 10,000,000 | +100.0% | 0.28% | – | |
New | CYTOKINETICS INCnote 3.500% 7/0 | $2,559,300 | – | 3,000,000 | +100.0% | 0.10% | – | |
New | CONMED CORPnote 2.250% 6/1 | $2,392,500 | – | 2,500,000 | +100.0% | 0.09% | – | |
New | OKTA INCnote 0.125% 9/0 | $1,821,000 | – | 2,000,000 | +100.0% | 0.07% | – | |
New | SPIRIT AIRLS INCnote 1.000% 5/1 | $1,673,000 | – | 2,000,000 | +100.0% | 0.06% | – | |
New | WAYFAIR INCnote 1.000% 8/1 | $1,645,000 | – | 2,000,000 | +100.0% | 0.06% | – | |
BAX | New | BAXTER INTL INC | $943,500 | – | 25,000 | +100.0% | 0.04% | – |
New | DEXCOM INCnote 0.250%11/1 | $842,328 | – | 889,000 | +100.0% | 0.03% | – | |
CGC | New | CANOPY GROWTH CORP | $386,669 | – | 500,000 | +100.0% | 0.02% | – |
New | ALLURION TECHNOLOGIES INC*w exp 07/31/202 | $111,475 | – | 122,500 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NICE SYS INC | 19 | Q3 2023 | 6.3% |
BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2023 | 0.8% |
EURONET WORLDWIDE ORD | 18 | Q3 2023 | 0.4% |
CLEVELAND CLIFFS ORD | 17 | Q3 2023 | 1.9% |
AIR TRANSPORT SERVICES GRP I | 17 | Q1 2023 | 0.5% |
LIBERTY MEDIA CORP DELAWARE | 16 | Q3 2023 | 5.6% |
ECHOSTAR CORP | 16 | Q3 2023 | 0.9% |
BAUSCH HEALTH COS INC | 15 | Q1 2023 | 0.3% |
O-I GLASS INC | 15 | Q3 2023 | 0.2% |
JAZZ PHARMACEUTICALS PLC | 14 | Q3 2023 | 0.1% |
View Aequim Alternative Investments LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-15 |
13F-HR | 2023-08-10 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-14 |
SC 13G | 2023-01-10 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-10 |
View Aequim Alternative Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.